2018
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.
Clinical pharmacology and therapeutics
PubMed • Publisher's siteResearch at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 80 publications
- Percutaneous Coronary Intervention , 43 publications
- Purinergic P2Y Receptor Antagonists , 42 publications
- Blood Platelets , 38 publications
Research activity
My publications
Filter publications
122 publications
2018
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease: Results of the SWAP-4 Study.
Circulation
PubMed • Publisher's site2018
Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside.
Journal of cardiovascular pharmacology and therapeutics
PubMed • Publisher's site2018
Role of genetic testing in patients undergoing percutaneous coronary intervention.
Expert review of clinical pharmacology
PubMed • Publisher's site2018
Standard- and Low-Dose Ticagrelor After Percutaneous Coronary Intervention: Finding the Balance for Patients With Stable Coronary Artery Disease.
Circulation
PubMed • Publisher's site